Garlic

In a clinical pharmacokinetic study in 10 healthy volunteers, allicin-containing garlic supplements taken twice daily for 3 weeks decreased saquinavir AUC by 51%, trough levels by 49%, and Cmax by 54%. The mechanism involves induction of intestinal CYP3A4 and P-glycoprotein by garlic organosulfur compounds, significantly reducing saquinavir first-pass bioavailability. Levels did not fully recover after 10-day washout.

Avoid garlic supplements with saquinavir as a sole protease inhibitor. Allow 10+ days washout after discontinuing garlic before initiating saquinavir. Monitor HIV viral load closely if concurrent use is identified. Dietary garlic amounts may be acceptable.

Garlic reduces platelet aggregation via ajoene-mediated TXA2 synthesis inhibition and may inhibit CYP2C9 (primary S-warfarin metabolizing enzyme). In vitro human hepatocyte studies showed greater than 90% reduction in CYP2C9 activity with garlic extract. Case reports document increased INR and bleeding events with garlic supplement use in warfarin patients.

Monitor INR regularly when garlic supplements are added to warfarin therapy. Dose adjustment may be required. Aged garlic extract may have a safer profile. Discontinue garlic supplements 7-10 days before surgery to reduce bleeding risk.

Garlic reduces platelet aggregation through ajoene-mediated inhibition of TXA2 synthesis and platelet activating factor antagonism. This antiplatelet activity is additive to aspirin irreversible COX-1 inhibition and clopidogrel ADP receptor antagonism, compounding bleeding risk when these drugs are co-administered.

Advise patients on antiplatelet therapy to use garlic supplements cautiously. Monitor for signs of unusual bruising or bleeding. Discontinue garlic supplements at least 7-10 days before any surgical procedure. Dietary garlic amounts are lower risk.

Garlic has documented hypoglycemic properties via alpha-glucosidase inhibition, enhancement of insulin sensitivity, and stimulation of insulin secretion. Animal studies demonstrate enhanced hypoglycemic effect of gliclazide when combined with Allium sativum. Additive blood glucose lowering may result in clinically significant hypoglycemia.

Monitor blood glucose more frequently when garlic supplements are added to antidiabetic therapy. Dose adjustment of antidiabetic medications may be required. Educate patients about hypoglycemia symptoms. Dietary garlic is lower risk than high-dose supplements.

Garlic demonstrates vasodilatory and blood pressure lowering effects via hydrogen sulfide release, NO-mediated smooth muscle relaxation, and ACE inhibition by allicin and related organosulfur compounds. Combined with prescribed antihypertensives, additive blood pressure reduction may occur and potentially cause hypotension.

Monitor blood pressure in patients combining garlic supplements with antihypertensive medications. Dose adjustments to antihypertensives may be required if blood pressure drops below therapeutic targets. Dietary garlic is lower risk.

Case reports document severe gastrointestinal toxicity in HIV patients taking ritonavir with garlic supplements. Garlic may alter intestinal P-glycoprotein expression and CYP3A4 activity, with bidirectional effects on antiretroviral plasma levels depending on garlic preparation and allicin content.

Avoid garlic supplements in patients on ritonavir-boosted antiretroviral regimens. Monitor antiretroviral plasma levels and viral load if concurrent use is identified. Odorless or aged garlic products may have reduced interaction potential.